471 related articles for article (PubMed ID: 9758693)
1. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
2. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
Johnson-Léger C; Christenson JR; Holman M; Klaus GG
J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
[TBL] [Abstract][Full Text] [Related]
4. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
Crawford DH; Catovsky D
Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
[TBL] [Abstract][Full Text] [Related]
5. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
[TBL] [Abstract][Full Text] [Related]
6. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
7. CD72 ligation regulates defective naive newborn B cell responses.
Howard LM; Reen DJ
Cell Immunol; 1997 Feb; 175(2):179-88. PubMed ID: 9023424
[TBL] [Abstract][Full Text] [Related]
8. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells.
Nagumo H; Agematsu K; Shinozaki K; Hokibara S; Ito S; Takamoto M; Nikaido T; Yasui K; Uehara Y; Yachie A; Komiyama A
J Immunol; 1998 Dec; 161(12):6496-502. PubMed ID: 9862673
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity.
Yellin MJ; Sinning J; Covey LR; Sherman W; Lee JJ; Glickman-Nir E; Sippel KC; Rogers J; Cleary AM; Parker M
J Immunol; 1994 Jul; 153(2):666-74. PubMed ID: 7517421
[TBL] [Abstract][Full Text] [Related]
11. Immunobiology of chronic lymphocytic leukemia.
Freedman AS
Hematol Oncol Clin North Am; 1990 Apr; 4(2):405-29. PubMed ID: 2182599
[TBL] [Abstract][Full Text] [Related]
12. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration.
Nishioka Y; Lipsky PE
J Immunol; 1994 Aug; 153(3):1027-36. PubMed ID: 7517971
[TBL] [Abstract][Full Text] [Related]
13. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
14. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling.
Jacquot S; Kobata T; Iwata S; Morimoto C; Schlossman SF
J Immunol; 1997 Sep; 159(6):2652-7. PubMed ID: 9300684
[TBL] [Abstract][Full Text] [Related]
15. CD40 preferentially costimulates activation of CD4+ T lymphocytes.
Cayabyab M; Phillips JH; Lanier LL
J Immunol; 1994 Feb; 152(4):1523-31. PubMed ID: 7509825
[TBL] [Abstract][Full Text] [Related]
16. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function.
Yellin MJ; Sippel K; Inghirami G; Covey LR; Lee JJ; Sinning J; Clark EA; Chess L; Lederman S
J Immunol; 1994 Jan; 152(2):598-608. PubMed ID: 7506727
[TBL] [Abstract][Full Text] [Related]
17. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
Grabstein KH; Maliszewski CR; Shanebeck K; Sato TA; Spriggs MK; Fanslow WC; Armitage RJ
J Immunol; 1993 Apr; 150(8 Pt 1):3141-7. PubMed ID: 7682232
[TBL] [Abstract][Full Text] [Related]
18. Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors.
Renard N; Duvert V; Blanchard D; Banchereau J; Saeland S
J Immunol; 1994 Feb; 152(4):1693-701. PubMed ID: 7509827
[TBL] [Abstract][Full Text] [Related]
19. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
20. Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
Schuler M; Tretter T; Schneller F; Huber C; Peschel C
Immunobiology; 1999 Feb; 200(1):128-39. PubMed ID: 10084701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
